Veradigm Inc. (MDRX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Veradigm Inc. (MDRX:NASDAQ), powered by AI.

Current Price
$4.85
Sector
Healthcare
What is the Veradigm Inc. stock price forecast?

Veradigm Inc. is currently trading at $4.85. View real-time AI analysis on Alpha Lenz.

What is Veradigm Inc. insider trading activity?

View the latest insider trading data for Veradigm Inc. on Alpha Lenz.

What is Veradigm Inc.'s P/E ratio?

View Veradigm Inc.'s valuation metrics on Alpha Lenz.

Veradigm Inc.

NASDAQ · MDRX
$4.85+0.05(+1.04%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Veradigm Inc.'s future dividend policy...
Alpha Chat Insight

Veradigm Inc.'s ROE is -7.3%. Explore profitability and growth together.

Ask for details

Company Overview

Veradigm Inc. is a healthcare technology company specializing in data-driven solutions that connect providers, payers, and life science organizations. The company’s core offerings include electronic health records (EHR), practice management software, and analytics tools designed to optimize clinical, financial, and operational outcomes. It serves over 180,000 physicians and supports 2,700 hospitals through platforms that enhance care coordination, patient engagement, and population health management. Veradigm leverages its extensive healthcare data network to deliver actionable insights for clinical research, revenue cycle management, and value-based care initiatives. Historically known as Allscripts, the company rebranded in 2023 to reflect its focus on scalable, AI-enhanced solutions. Despite recent regulatory challenges, including a 2024 Nasdaq suspension for delayed financial filings, Veradigm remains a significant player in healthcare IT, bridging gaps across the ecosystem through interoperable technology and data interoperability standards.

CEOMr. Thomas J. Langan
SectorHealthcare
IndustryHealth Information Services
Employees2,450

Company Statistics

FY 2022

Profile

N/AMarket Cap
$588.02MRevenue
0.00Shares Out
2,450Employees

Margins

52.45%Gross
11.45%EBITDA
-3.33%Operating
-10.86%Pre-Tax
-14.70%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-28.85%Rev 3Yr
-17.05%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-4.53%ROA
-7.27%ROE
-3.01%ROIC

Financial Health

$446.59MCash & Cash Equivalents
$40.62MNet Debt
47.88%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Veradigm Inc. (ticker: MDRX) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 2,450 employees.

The current price is $4.85 with a P/E ratio of -x and P/B of -x.

ROE is -7.27% and operating margin is -3.33%. Annual revenue is $588M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Veradigm Inc. (MDRX) Stock Forecast 2026 $4.85 — Price, Financials & Analyst Targets | Alpha Lenz